Technology News and Research

RSS

Regenstrief Institute awarded Recovery Act contract to automate disability case determinations

The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.

30 Mar 2010

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Former England Rugby World Cup winner Matt Dawson today launched the 'Because Life is for Living' campaign to raise awareness about brachytherapy, a very precise and highly effective form of radiotherapy to treat cancer.

30 Mar 2010

Sectra's method for effective multi-site workflow and rapid image data delivery receives U.S. patent

“Two crucial challenges for the future of radiology are the ever-growing size of imaging data sets and the increased needs for sharing and remote reading. Sectra's innovation has enabled us to create unique and future-proof solutions to these challenges”

30 Mar 2010

U.Va. develops Prostate Exam Simulator

Early detection through physical examination is one of the key factors in successfully treating prostate cancer.

30 Mar 2010

Researchers working on full-page Braille display system to help blind read better

Imagine if your computer only allowed you to see one line at a time, no matter what you were doing - reading e-mail, looking at a Web site, doing research. That's the challenge facing blind computer users today. But new research from North Carolina State University is moving us closer to the development of a display system that would allow the blind to take full advantage of the Web and other computer applications.

30 Mar 2010

New therapeutic approaches against lymphoid tumors

Helmholtz Zentrum M-nchen has launched a new cooperative project with SIRION BIOTECH GmbH in Martinsried to develop new therapeutic approaches against lymphoid tumors. With a two-year grant from the Federal Ministry for Economics and Technology, the two partners will seek to further develop lentiviral vector systems to better understand the disease mechanisms of this cancer form and to devise approaches for treatment.

30 Mar 2010

BRIC ministers reach agreement on promoting global food security

Brazil, Russia, India and China, collectively known as BRIC, have reached an agreement to promote global food security, the Moscow Times reports (Anishyuk, 3/29).

30 Mar 2010

New DNA test to detect Lyme disease spirochete infection

Many of the more than 30,000 people a year in the United States with suspected cases of Lyme disease spirochete (bacterial) infection can now take a DNA test developed by a Connecticut scientist/physician and his team that can quickly determine if they test positive for Lyme spirochetes in their blood.

30 Mar 2010

MEDSEEK expands relationship with Frederick Memorial to develop eHealth ecoSystem

MEDSEEK, the leading provider of healthcare enterprise portal connectivity solutions, announced today the expansion of its relationship with long-time partner Frederick Memorial with its engagement to develop the healthcare organization's comprehensive eHealth ecoSystem.TM

30 Mar 2010

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.

30 Mar 2010

New home health provisions proposed in Health Care Reform Bill to benefit older patients

New home health provisions proposed in the Health Care Reform Bill (H.R. 3590 Patient Protection and Affordable Care Act) will support the testing and implementation of in-home health care services for chronically ill elderly residents of Greater Philadelphia.

30 Mar 2010

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.

30 Mar 2010

Royal Philips Electronics introduces InnerCool RTx Endovascular System

Royal Philips Electronics announced today its launch of the Philips InnerCool RTx Endovascular System for cooling and warming, which provides advanced whole body temperature modulation therapy in a closed-loop system from the inside out. The InnerCool RTx is a high-performance system that can rapidly raise and lower the body temperature of certain non-paralyzed, awake patients of all sizes in the intensive care setting.

From Philips Healthcare 30 Mar 2010

Adoption of healthcare IT is on steady incline in small physician practice: NaviNet survey

Adoption of healthcare IT is on a steady incline in the small physician practice, reveals a survey by NaviNet, America's largest real-time healthcare communications network. In early March 2010, NaviNet conducted a survey of IT and electronic medical record adoption trends in small practices and compared results to a similar survey the company issued to small practices in August 2009.

30 Mar 2010

Enrollment complete in Paradigm Spine's comparative study of coflex interlaminar technology

Paradigm Spine, LLC, a developer of innovative non-fusion and fusion spinal implant solutions, announced today that it has completed patient enrollment in an Investigational Device Exemption pivotal clinical study comparing the coflex® interlaminar technology to instrumented posterolateral fusion in the surgical treatment of spinal stenosis.

30 Mar 2010

LCT receives approval for New Zealand Phase II human trial of DIABECELL

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today announced that it has received approval to advance to the next phase of its New Zealand Phase II human clinical trial with its groundbreaking DIABECELL®. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its DIABACELL® implants.

30 Mar 2010

DIATHERIX GI test panel can detect nine types of GI infections

DIATHERIX Laboratories adds a gastrointestinal panel to its lineup of highly sensitive, rapid response diagnostic tests. In a single result, the DIATHERIX GI panel can detect and differentiate nine types of GI infections so physicians can quickly identify patients who have severe, life-threatening infections.

30 Mar 2010

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

30 Mar 2010

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

29 Mar 2010

National Institute of Mental Health awards two-year, $998,940 grant for autism research

An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.

29 Mar 2010

Technology News and Research

Regenstrief Institute awarded Recovery Act contract to automate disability case determinations

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Sectra's method for effective multi-site workflow and rapid image data delivery receives U.S. patent

U.Va. develops Prostate Exam Simulator

Researchers working on full-page Braille display system to help blind read better

New therapeutic approaches against lymphoid tumors

BRIC ministers reach agreement on promoting global food security

New DNA test to detect Lyme disease spirochete infection

MEDSEEK expands relationship with Frederick Memorial to develop eHealth ecoSystem

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

New home health provisions proposed in Health Care Reform Bill to benefit older patients

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Royal Philips Electronics introduces InnerCool RTx Endovascular System

Adoption of healthcare IT is on steady incline in small physician practice: NaviNet survey

Enrollment complete in Paradigm Spine's comparative study of coflex interlaminar technology

LCT receives approval for New Zealand Phase II human trial of DIABECELL

DIATHERIX GI test panel can detect nine types of GI infections

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

National Institute of Mental Health awards two-year, $998,940 grant for autism research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News